Cargando…
New Therapeutic Targets in Autoimmune Cholangiopathies
Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are autoimmune cholangiopathies characterized by limited treatment options. A more accurate understanding of the several pathways involved in these diseases has fostered the development of novel and promising targeted drugs....
Autores principales: | Gerussi, Alessio, Lucà, Martina, Cristoferi, Laura, Ronca, Vincenzo, Mancuso, Clara, Milani, Chiara, D'Amato, Daphne, O'Donnell, Sarah Elizabeth, Carbone, Marco, Invernizzi, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154090/ https://www.ncbi.nlm.nih.gov/pubmed/32318580 http://dx.doi.org/10.3389/fmed.2020.00117 |
Ejemplares similares
-
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison
por: Montali, Lorenzo, et al.
Publicado: (2021) -
Artificial intelligence for precision medicine in autoimmune liver disease
por: Gerussi, Alessio, et al.
Publicado: (2022) -
Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients
por: Gerussi, Alessio, et al.
Publicado: (2020) -
Primary Sclerosing Cholangitis: Burden of Disease and Mortality Using Data from the National Rare Diseases Registry in Italy
por: Carbone, Marco, et al.
Publicado: (2020) -
The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)